openPR Logo
Press release

Hip Osteoarthritis Pain Drug Market Size, Share, Analysis, Industry Report and Forecast 2022-2028

03-30-2022 11:46 AM CET | Health & Medicine

Press release from: Orion Market Research

The global hip osteoarthritis pain drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The common symptoms of hip osteoarthritis include pain around groin area of the hip (area between the upper thigh and lower abdomen). Generally, this pain starts gradually and gets worsen over time if not treated on time. The major factors attributable to the growth of the hip osteoarthritis pain drug market include the rising prevalence of hip osteoarthritis due to aging, excess weight gain, and in some cases, due to genetic causes. It majorly affects the articular cartilage which results in changes to synovium, ligaments, capsules, and subchondral bone. According to the World Health Organization (WHO), hip osteoarthritis stands in top 15 contributors of global disability. Additionally, it is mainly diagnosed in people of age above 65, where 50% of the cases are symptomatic. In addition, as per the survey conducted by the Centers for Disease Control and Prevention (CDC), lifetime risk has been associated with hip osteoarthritis which is 18.5% for men, and 28.6% for women.

To Request a Sample of our Report on Hip Osteoarthritis Pain Drug Market: https://www.omrglobal.com/request-sample/hip-osteoarthritis-pain-drug-market

Some key players operating in the market include Teva Pharmaceutical Industries Ltd., Pfizer Inc., and Bayer AG, among others. These market players are continuously focusing on introducing new drug drugs catering to cure the pain of hip or knee joints. For instance, in May 2020, Novartis introduced a new drug named as interleukin-1 inhibitor canakinumab, which will relatively reduce the overall of the cost associated with hip or knee replacement and will also decrease osteoarthritis symptoms. The drug has been published by Annals of Internal Medicine later in November 2020 stating the advantages of the drugs.

Market Coverage

· The market number available for - 2021-2028

· Base year- 2021

· Forecast period- 2022-2028

Segment Covered-

· By Type

· By Distribution Channel

Regions covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape: Teva Pharmaceutical Industries Ltd., Pfizer Inc., and Bayer AG, among others.

(Get 15% Discount on Buying this Report)

A full Report of Hip Osteoarthritis Pain Drug Market is Available @ https://www.omrglobal.com/industry-reports/hip-osteoarthritis-pain-drug-market

Global Hip Osteoarthritis Pain Drug Market Report by Segment

By Type

· Oral

· Injection

· Others

By Distribution Channel

· Online

· Offline

Global Hip Osteoarthritis Pain Drug Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hip Osteoarthritis Pain Drug Market Size, Share, Analysis, Industry Report and Forecast 2022-2028 here

News-ID: 2590849 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Hip

Gospel Hip Hop and Christian Hip Hop has Its Hall of Fame: Emcee N.I.C.E. Induct …
Dr. Aulsondro "Novelist" Hamilton, professionally known as Emcee N.I.C.E., was honored with a prestigious induction into the Gospel Hip Hop and Christian Hip-Hop Hall of Fame during a remarkable ceremony held at the Black Wall Street Market in Atlanta, Georgia. The establishment of a Gospel Hip Hop (GHH) and Christian Hip Hop (CHH) Hall of Fame was created to provide long-overdue recognition to artists who have made significant contributions to the
Hip Replacement Market - Restoring Motion, Reclaiming Life: Hip Replacement for …
Newark, New Castle, USA: The "Hip Replacement Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Hip Replacement Market: https://www.growthplusreports.com/report/hip-replacement-market/7789 This latest report researches the industry structure, sales, revenue,
Have Hip Pain? See The Total Hip Replacement Guide
Regardless of whether you have just started started investigating treatment choices or have effectively chosen to a hip replacement medical procedure, we hope this data will enable you to comprehend the advantages and disadvantages of total hip replacement surgery. This article depicts how typical hip functions, the reasons for hip pain, what’s in store from with a THR (Total Hip Replacement), and what activities and exercises will help reestablish your
HIP Replacement Devices Market Report 2018: Segmentation by Product (Product (Pr …
Global HIP Replacement Devices market research report provides company profile for Zimmer Inc. (U.S.), DePuy Synthes (U.S.), Stryker (U.K.), Smith & Nephew (U.K.), B. Braun Melsungen AG (Germany), Corin (U.K.), and Waldemar LINK GmbH & Co. KG (Germany) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,
Hip Replacement Implant Market: Rising Incidence of Hip Bone Disorders Fuels Gro …
The top three players in the global hip replacement market, collectively, contributed 74.7% of the overall revenue generation of the market in 2015, indicating towards consolidated nature of this arena. These players are Johnson & Johnson, Zimmer Biomet Holdings Inc., and Stryker Corporation. Transparency Market Research (TMR) observes that strong portfolio, high geographic outreach, and strong brand recognition are some of the factors contributing to the dominance of these companies.
Bernstein Liebhard LLP Applauds FDA’s Request that Hip Manufacturers Produce D …
Bernstein Liebhard LLP Applauds FDA’s Request that Hip Manufacturers Produce Data on Metal Poisoning and Hip Implants New York 5/12/2011 04:40 PM GMT (TransWorldNews) On May 6, 2011, the U.S Food and Drug Administration (“FDA”) ordered 21 medical device manufacturers, including Johnson & Johnson, Zimmer and Stryker, to conduct post-market analysis to determine whether their metal-on-metal hip replacement implants put patients at an increased risk for chromium and cobalt poisoning.